Learning Objectives:

1. Review the progression of immunosuppressive therapy drug development over last two decades.
2. Highlight the barriers for clinical investigation and innovation in transplantation.
3. Review possible primary endpoints and relevance of biomarkers.
4. Educate on a recent initiative with FDA to advance transplant therapeutics.